Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial


Publication type
Article
Language
English
Access rights
Restricted access
Appears in Collections:
Metrics
Reference
Kallas EG, Precioso AR, Palacios R, Thomé B, Braga PE, Vanni T, et al. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial. Lancet Infect. Dis.. 2020 Mar;20(7):839-850. doi:10.1016/S1473-3099(20)30023-2.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/2991
URL
https://doi.org/10.1016/S1473-3099(20)30023-2
Issue Date
2020

Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.